Core Viewpoint - Huarong Chemical (301256) is actively engaging in financial management and risk mitigation strategies, including providing guarantees for subsidiaries and conducting foreign exchange hedging to manage currency risk. Trading Information Summary - As of January 9, 2026, Huarong Chemical's stock closed at 17.42 yuan, up 2.65%, with a turnover rate of 11.86%, trading volume of 569,300 shares, and a transaction value of 973 million yuan [1] - On the same day, the net inflow of main funds was 18.09 million yuan, while retail investors experienced a net outflow of 1.66 million yuan [1] Company Announcement Summary - The second board meeting of Huarong Chemical on January 8, 2026, approved several proposals, including providing guarantees for subsidiaries, using idle funds for cash management, applying for comprehensive credit from financial institutions, and conducting foreign exchange hedging [1][3] - A temporary shareholders' meeting is scheduled for January 26, 2026, to review the proposals, including the guarantee for subsidiaries and cash management [1] Guarantee for Subsidiaries - Huarong Chemical plans to provide a total guarantee of up to 2.54 billion yuan for its subsidiaries, with 1.25 billion yuan for subsidiaries with a debt-to-asset ratio of 70% or higher, and 1.29 billion yuan for those below that threshold [2][3] - As of December 31, 2025, the actual guarantee amount was 458.67 million yuan, accounting for 26.50% of the latest audited net assets [2] Foreign Exchange Hedging - The company intends to conduct foreign exchange hedging due to increased foreign currency settlement needs, with a maximum contract value of 10 million USD per trading day and a maximum margin and premium of 6.5 million USD [3][6] - The hedging will include products such as forward foreign exchange settlements, foreign exchange swaps, and options, with a focus on USD and EUR [2][3] Cash Management - Huarong Chemical plans to use up to 1.5 billion yuan for cash management, including a maximum of 400 million yuan from idle raised funds, with a rolling usage period of 12 months [5][6] - Investment products will include low-risk options such as structured deposits, notice deposits, and time deposits [5][6]

Group 1 - The company held its 15th meeting of the second board of directors on January 8, 2026, where several key resolutions were passed [2][3][9] - The board approved a proposal to provide guarantees for subsidiaries with a total limit of up to 254 million yuan, which includes 125 million yuan for subsidiaries with a debt-to-asset ratio of 70% or more [51][53] - The board also approved a proposal to use part of the idle raised funds and self-owned funds for cash management, with a total limit of up to 150 million yuan, including a maximum of 40 million yuan from idle raised funds [31][32] Group 2 - The company plans to apply for a comprehensive credit line of up to 3.04 billion yuan from financial institutions to meet its funding needs for 2026 [9][10] - The board approved a proposal to conduct foreign exchange hedging business, with a maximum contract value of 100 million USD and a maximum margin and premium of 6.5 million USD [14][16] - The foreign exchange hedging aims to mitigate risks associated with currency fluctuations and improve the efficiency of foreign exchange fund usage [16][18] Group 3 - The company will hold its first extraordinary general meeting of 2026 on January 26, 2026, to discuss the resolutions passed by the board [62][63] - The meeting will be conducted both in-person and via online voting, ensuring participation from shareholders [65][66] - The company emphasizes that all resolutions will be counted separately for minority shareholders to protect their interests [70]

Core Viewpoint - Huarong Chemical (301256) has experienced a decline in stock price, closing at 16.97 yuan, a decrease of 2.02% from the previous trading day, with a total market capitalization of 8.146 billion yuan [1] Group 1: Stock Performance - The stock opened at 17.8 yuan, reached a high of 18.5 yuan, and a low of 16.93 yuan during the trading session [1] - The trading volume for the day was 1.243 billion yuan, with a turnover rate of 14.69% [1] Group 2: Upcoming Shareholder Meeting - Huarong Chemical announced the first extraordinary general meeting of 2026, scheduled for January 26, 2026, with a record date of January 20, 2026 [1] - The meeting will discuss proposals regarding providing guarantees for subsidiaries and using part of the idle raised funds (including oversubscribed funds) and self-owned funds for cash management, with the guarantee proposal requiring a special resolution [1] - Voting will be conducted both on-site and online, with separate counting for minority investors [1]

Group 1 - The core point of the article is that Huarong Chemical announced the approval of several proposals, including a motion to provide guarantees for its subsidiaries during the 15th meeting of its second board of directors [2] Group 2 - The announcement indicates the company's ongoing support for its subsidiaries, which may enhance their operational capabilities and financial stability [2] - The decision reflects the company's strategic focus on strengthening its subsidiary operations through financial backing [2]

Core Viewpoint - Huarong Chemical announced the approval of a total guarantee amount of 284 million yuan for its subsidiaries, with an actual guarantee amount of 45.87 million yuan, representing 26.50% of the company's latest audited net assets [1] Summary by Categories Company Guarantees - The total guarantee amount approved by the company's shareholders and board for subsidiaries is 284 million yuan [1] - The actual amount of guarantees provided is 45.87 million yuan [1] - The actual guarantee amount constitutes 26.50% of the company's most recent audited net assets [1] Legal and Financial Status - The company and its controlling subsidiaries do not have any guarantees provided to entities outside the consolidated financial statements [1] - There are no overdue guarantees or guarantees involved in litigation [1]

Group 1 - The company Huarong Chemical (301256) announced that it will hold its first extraordinary general meeting of shareholders in 2026 on January 26 [1]

Core Viewpoint - Huarong Chemical announced the approval of a foreign exchange hedging business to mitigate foreign exchange market risks [2] Group 1: Business Strategy - The company plans to engage in foreign exchange hedging activities with qualified financial institutions, including banks approved by relevant government departments [2] - The maximum contract value held on any trading day will not exceed 100 million USD, with a maximum limit of 6.5 million USD for transaction margin and premiums [2] Group 2: Financial Instruments - The hedging activities will include various financial products such as forward foreign exchange contracts, foreign exchange swaps, foreign exchange options, interest rate swaps, interest rate options, and currency swaps, or combinations of these products [2]

每经AI快讯，华融化学1月8日晚间发布公告称，截至公告披露日，公司股东会、董事会审议通过的为 子公司提供担保总额度为28.4亿元，实际担保金额为4.59亿元，实际担保金额占公司最近一期经审计净 资产的比例为26.50%。 截至公告披露日，公司及控股子公司不存在对合并报表外单位提供的担保，不存在逾期担保、涉讼担 保。 每经头条（nbdtoutiao）——培训5天就考证！滑雪教练速成班乱象调查：零基础也可报名，学时还 能"注水" （记者 王晓波） ...

关于华融化学股份有限公司 华泰联合证券有限责任公司 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐机构"） 作为华融化学股份有限公司（以下简称"华融化学"或"公司"或"上市公司"） 首次公开发行股票并在创业板上市（以下简称"本次发行"）之保荐机构，根据 《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票上市规则》《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等 规定，就华融化学开展外汇套期保值业务的事项进行了核查，核查情况及核查意 见如下： 一、外汇套期保值业务的基本情况 授权期限内任一交易日开展套期保值业务的持有最高合约价值不超过 1 亿 美元，预计动用的交易保证金和权利金上限不超过 650 万美元，可在审批的有效 期限内循环滚动使用。 （三）交易方式 公司及子公司的外汇套期保值业务仅限于实际业务发生的币种（主要币种为 美元、欧元）。公司进行外汇套期保值业务包括但不限于远期结售汇、外汇掉期、 外汇期权、利率掉期、利率期权、货币互换等产品或上述产品的组合，以及其他 外汇衍生品业务。 （四）交易期限 开展外汇套期保值业务的核查意见 （一）投资目的 随着公司海外业 ...

华泰联合证券有限责任公司 关于华融化学股份有限公司 使用部分闲置募集资金（含超募资金）和自有资金 进行现金管理的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合"或"保荐机构"）作为华融 化学股份有限公司（以下简称"华融化学"或"公司"或"上市公司"）首次公开发行 股票并在创业板上市（以下简称"本次发行"）之保荐机构，根据《证券发行上市 保荐业务管理办法》《上市公司募集资金监管规则》《深圳证券交易所创业板股票 上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司 规范运作》等规定，就华融化学使用使用部分闲置募集资金（含超募资金）和自 有资金进行现金管理事项进行了核查，核查情况及核查意见如下： 截至 2025 年 12 月 31 日，公司募集资金余额 40,626.60 万元，其中仍在进 行现金管理尚未到期的募集资金金额 39,204.00 万元。 一、募集资金到账情况 经深圳证券交易所核准并经中国证券监督管理委员会注册（证监许可〔2022〕 252 号），公司获准首次公开发行人民币普通股 12,000 万股，每股发行价格人民 币 8.05 元，募集资金总额 966,000,000. ...